RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Alexandria Venture Investments
A

Alexandria Venture Investments portfolio

Alexandria Venture Investments has 24 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 24.
Deals, last 12 months: 1.
Capital in their rounds: $1.57B.
Latest deal: Precede · Jan 12, 2026.
About this page

Its most recent investment on record is Precede's $83.5M Series B+ round in January 2026, alongside Illumina Ventures, Lilly Asia Ventures, OUP and 6 others. By category, its portfolio leans toward Health and bio (23) and Data and analytics (2). It has co-invested with ARCH Venture Partners, GV and 8VC, most often ARCH Venture Partners (5 rounds).

What Alexandria Venture Investments invests in

Alexandria Venture Investments recent investments

How Alexandria Venture Investments invests

StageDealsCapital in rounds
Series A 9 60%$966M
Series B+ 5 33%$595.5M
Seed 1 7%$6.5M
YearDealsCapital in rounds
2017 1 7%$55M
2019 1 7%$6.5M
2020 2 13%$86M
2021 2 13%$290M
2022 2 13%$157M
2023 1 7%$100M
2024 3 20%$557M
2025 2 13%$233M
2026 1 7%$83.5M

Alexandria Venture Investments portfolio companies

CompanyRound with Alexandria Venture InvestmentsTotal raisedLatest raise
PPrecede
Health and bio
Series B+ · $83.5M$83.5MJan 12, 2026
Series B+
NNilo Therapeutics
Health and bio
Series A · $101M$101MOct 8, 2025
Series A
AARTBIO
Health and bio
Series B+ · $132M$245MJul 29, 2025
Series B+
BBright Peak Therapeutics
Health and bio
Series B+ · $90M$125MAug 17, 2026
Series B+
DDelphia Therapeutics
Health and bio
Series A · $67M$67MMay 2, 2024
Series A
MMirador Therapeutics
Health and bio
Series A · $400M$650MJan 13, 2026
Series B+
PParatus Sciences
Health and bio
Series A · $100M$100MMar 8, 2023
Series A
MMatchpoint Therapeutics
Health and bio
Series A · $100M$250MOct 7, 2026
Series B+
CCartography Biosciences
Health and bio
Series A · $57M$124MOct 2, 2025
Series B+
IImmunai
Health and bio
Series B+ · $215M$295MOct 28, 2021
Series B+
EEncodia
Health and bio
Series B+ · $75M$75MJun 26, 2024
Series A
DDren Bio
Health and bio
Series A$415MOct 29, 2026
round
MMOMA Therapeutics
Health and bio
Series A · $86M$236MMay 10, 2022
Series B+
AAspen Neuroscience
Health and bio
Seed · $6.5M$339MNov 20, 2025
Series B+
LLifeMine Therapeutics
Health and bio
Series A · $55M$543MAug 6, 2026
Series B+
KKhartis Therapeutics
Health and bio
backer$95MAug 13, 2026
Series B+
OOverT Bio
Health and bio
backer$16MMay 6, 2024
Seed
IInspirna
Health and bio
backer$50MJul 11, 2022
Series B+
JJupiter Bioventures
Health and bio
backerundisclosedOct 8, 2025
Series B+
XXilis
Health and bio
backer$92MSep 16, 2022
Series A
AAdaptive Phage Therapeutics
Health and bio
backer$85MJun 13, 2023
Series B+
SSoli Organic
Commerce and retail
backer$125MOct 12, 2022
round
SSeawolf Therapeutics
Health and bio
backer$100MNov 16, 2026
Seed
AAffini-T
Health and bio
backer$175MMar 22, 2022
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 15 rounds on Recent Funding that name Alexandria Venture Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Alexandria Venture Investments, which is a subset of its real portfolio. API: /api/v1/investors/alexandria-venture-investments (get a free API key). More: the most active VC firms and new venture capital funds.